| Hermans C, Slachmuylder V, Gala JL, et al.
The JAK2 V617F mutation is not a cause of central retinal vein occlusion. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):515-6.
Full Citation | Find Related Articles | | Donadini M, Dentali F, Squizzato A, et al.
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):513-4.
Full Citation | | de Moerloose P, Palareti G, Aguilar C, et al.
A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):505-12.
Abstract | Full Citation | | Asmis LM, Segal JB, Plantinga LC, et al.
Heparin-induced antibodies and cardiovascular risk in patients on dialysis. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):498-504.
Abstract | Full Citation | Find Related Articles | | Diamant M, Tushuizen ME, Abid-Hussein MN, et al.
Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):489-97.
Abstract | Full Citation | | Kimura C, Oike M
Heparan sulfate proteoglycan is essential to thrombin-induced calcium transients and nitric oxide production in aortic endothelial cells. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):483-8.
Abstract | Full Citation | Find Related Articles | | Weck M, Rietzsch H, Lawall H, et al.
Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):475-82.
Abstract | Full Citation | Find Related Articles | | Clark P, Wu O
ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):469-74.
Abstract | Full Citation | | van Vliet HH, Kappers-Klunne MC, Leebeek FW, et al.
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):462-8.
Abstract | Full Citation | | Mueck W, Borris LC, Dahl OE, et al.
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement. [Journal Article]
Thromb Haemost 2008 Sep; 100(3):453-61.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
